Influence of Season on Exacerbation Characteristics in Patients With COPD

被引:81
|
作者
Donaldson, Gavin C. [1 ]
Goldring, James J. [1 ]
Wedzicha, Jadwiga A. [1 ]
机构
[1] UCL Med Sch, Acad Unit Resp Med, London NW3 2PF, England
基金
英国医学研究理事会;
关键词
OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; RESPIRATORY VIRUSES; VIRAL-INFECTIONS; LUNG-FUNCTION; ADMISSIONS; DECLINE; INFLAMMATION; POPULATION; PREVENTION;
D O I
10.1378/chest.11-0281
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Patients with COPD experience more frequent exacerbations in the winter. However, little is known about the impact of the seasons on exacerbation characteristics. Methods: Between November 1, 1995, and November 1, 2009, 307 patients in the London COPD cohort (196 men; age, mean, 68.1 years [SD, 8.4]; FEV(1), mean, 1.12 L [SD, 0.46]; FEV(1), mean, % predicted, 44.4% [SD, 16.1]) recorded their increase in daily symptoms and time outdoors for a median of 1,021 days (interquartile range [IQR], 631-1,576). Exacerbation was identified as >= 2 consecutive days with an increase in two different symptoms. Results: There were 1,052 exacerbations in the cold seasons (November to February), of which 42.5% and 50.6% were patients who had coryzal and cough symptoms, respectively, compared with 676 exacerbations in the warm seasons (May to August), of which 31.4% and 45.4% were in patients who had coryzal and cough symptoms, respectively (P < .05). The exacerbation recovery period was longer in the cold seasons (10 days; IQR, 6-19) compared with the warm seasons (9 days; IQR, 5-16; P < .005). The decrease in outdoor activity during exacerbation, relative to a pre-exacerbation period (-14 to -8 days), was greater in the cold seasons (-0.50 h/d; IQR, -1.1 to 0) than in the warm seasons (-0.26 hid; IQR, -0.88 to 0.18; P = .048). In the cold seasons, 8.4% of exacerbations resulted in patients who were hospitalized, compared with 4.6% of exacerbations in the warm seasons (P = .005). Conclusions: Exacerbations are more severe between November and February. This contributes to the increased morbidity during the winter seasons. CHEST 2012; 141(1):94-100
引用
收藏
页码:94 / 100
页数:7
相关论文
共 50 条
  • [41] Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review
    Miravitlles, Marc
    D'Urzo, Anthony
    Singh, Dave
    Koblizek, Vladimir
    RESPIRATORY RESEARCH, 2016, 17
  • [42] Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
    Vogelmeier, Claus F.
    Chapman, Kenneth R.
    Miravitlles, Marc
    Roche, Nicolas
    Vestbo, Jorgen
    Thach, Chau
    Banerji, Donald
    Fogel, Robert
    Patalano, Francesco
    Olsson, Petter
    Kostikas, Konstantinos
    Wedzicha, Jadwiga A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 1125 - 1134
  • [43] Statins and outcome after hospitalization for COPD exacerbation: A prospective study
    Bartziokas, Konstantinos
    Papaioannou, Andriana I.
    Minas, Markos
    Kostikas, Konstantinos
    Banya, Winston
    Daniil, Zoe D.
    Haniotou, Aikaterini
    Gourgoulianis, Konstantinos I.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2011, 24 (05) : 625 - 631
  • [44] Effect of thyroid function on COPD exacerbation frequency: a preliminary study
    Ulasli, Sevinc Sarinc
    Bozbas, Serife Savas
    Ozen, Zeynep Erayman
    Ozyurek, Berna Akinci
    Ulubay, Gaye
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2013, 8
  • [45] Predictive accuracy of patient-reported exacerbation frequency in COPD
    Quint, J. K.
    Donaldson, G. C.
    Hurst, J. R.
    Goldring, J. J. P.
    Seemungal, T. R.
    Wedzicha, J. A.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (03) : 501 - 507
  • [46] Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history
    Bateman, E. D.
    Rabe, K. F.
    Calverley, P. M. A.
    Goehring, U. M.
    Brose, M.
    Bredenbroeker, D.
    Fabbri, L. M.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (03) : 553 - 560
  • [47] Influence of Previous-Year Physical Activity on the Cognition of Older COPD Patients During Exacerbation
    Torres-Sanchez, Irene
    Ortiz-Rubio, Araceli
    Cabrera-Martos, Irene
    Granados-Santiago, Maria
    Lopez-Torres, Isabel
    Carmen Valenza, Marie
    JOURNAL OF PHYSICAL ACTIVITY & HEALTH, 2020, 17 (05) : 519 - 524
  • [48] Blood and sputum eosinophilia in COPD exacerbation
    Helala, Laila Ashour
    AbdelFattah, Eman Badawy
    Abd Elsalam, Hazem Mohamed
    EGYPTIAN JOURNAL OF BRONCHOLOGY, 2022, 16 (01)
  • [49] Discriminate use of antibiotics for exacerbation of COPD
    Stolz, Daiana
    Tamm, Michael
    CURRENT OPINION IN PULMONARY MEDICINE, 2009, 15 (02) : 126 - 132
  • [50] Early experiences in COPD exacerbation detection
    Merone, Mario
    Onofri, Leonardo
    Soda, Paolo
    Pedone, Claudio
    Incalzi, Raffaele Antonelli
    Iannello, Giulio
    2014 IEEE 27TH INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS (CBMS), 2014, : 406 - 410